Legato III is a system for the global management of cutaneous imperfections and aging. By combining Microplasma iPixelRF technology with Ultrasound Impact technology, Legato ™️ trans-epidermal delivery (ITED) technology improves skin quality, reduces stretch marks and reduces sagging skin.

Action on scars, spots, stretch marks:

  • Rejuvenation of the face (elasticity and tonicity of the skin),
  • Photorejuvenation
  • Stretch mark mitigation
  • Discoloration and acceleration of scarring (acne scars or keloids …)

The treatment has three phases, adjustable according to the objectives:

1. The micro-ablative phase:

Fractional Radiofrequency produces vertical microchannels in the skin, up to the dermal-epidermal junction, by the “Microplasma” effect. These will serve as vectors for the actives to directly reach the subcutaneous tissues.

2. The thermal phase:

Unipolar Radio Frequency is an essentially thermal and profound action. This rise in temperature will generate inflammation of the fibroblasts, forcing them to create collagen and elastin.

3. Penetration of active molecules:

Active compounds intended to pass into the dermis (hyaluronic acid, retinoids, vitamins, peptides, organic silicon, etc.) are applied. Their penetration will be intensified by ultrasonic sonophoresis (alternating pressure and acoustic depressions).

The actions of Legato have a remarkable efficiency, both on the body and on the face.

This treatment fully meets the requirements of today’s active women for minimally invasive and painless aesthetic care. Moreover, it is suitable for any skin phototype (from light to dark) and its use does not require any social exclusion.